The too easy solution is more subsidies which only shift costs to the taxpayers or heavy handed price caps which can result in unintended consequences. But here's one idea worth reconsidering. Last year we proposed tying pharma price increases to the rate of inflation for generic drugs. That way pharmaceutical companies will still be incentivized to develop the next generation of therapies. But these drugs will be much more affordable once they're off patent. (13:39–13:47)
CLAIM
Asserts that a proposal was made to tie pharma price increases to inflation for generic drugs.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
